154 related articles for article (PubMed ID: 15794869)
21. Alkylating agents for Waldenstrom's macroglobulinaemia.
Yang K; Tan J; Wu T
Cochrane Database Syst Rev; 2009 Jan; (1):CD006719. PubMed ID: 19160296
[TBL] [Abstract][Full Text] [Related]
22. Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia.
Mulligan SP; Karlsson K; Strömberg M; Jønsson V; Gill D; Hammerström J; Hertzberg M; McLennan R; Uggla B; Norman J; Wallvik J; Sundström G; Johansson H; Brandberg Y; Liliemark J; Juliusson G;
Leuk Lymphoma; 2014 Dec; 55(12):2769-77. PubMed ID: 24524339
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Waldenstrom's macroglobulinemia with nucleoside analogues.
Dimopoulos MA; O'Brien S; Kantarjian H; Estey EE; Keating MJ; Alexanian R
Leuk Lymphoma; 1993; 11 Suppl 2():105-8. PubMed ID: 7907250
[TBL] [Abstract][Full Text] [Related]
24. Fludarabine therapy in a patient with progressive symptomatic Waldenström's macroglobulinemia.
Hałaburda K; Hellmann A
Acta Haematol Pol; 1994; 25(1):63-7. PubMed ID: 8209618
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: an update of a US intergroup trial (SW0G S9003).
Dhodapkar MV; Jacobson JL; Gertz MA; Crowley JJ; Barlogie B
Semin Oncol; 2003 Apr; 30(2):220-5. PubMed ID: 12720140
[TBL] [Abstract][Full Text] [Related]
26. Fludarabine treatment in resistant Waldenstrom's macroglobulinemia.
Zinzani PL; Gherlinzoni F; Bendandi M; Zaccaria A; Aitini E; Salvucci M; Tura S
Eur J Haematol; 1995 Feb; 54(2):120-3. PubMed ID: 7698295
[TBL] [Abstract][Full Text] [Related]
27. Waldenström's macroglobulinemia.
Dimopoulos MA; Galani E; Matsouka C
Hematol Oncol Clin North Am; 1999 Dec; 13(6):1351-66. PubMed ID: 10626154
[TBL] [Abstract][Full Text] [Related]
28. Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia.
Nguyen-Khac F; Lambert J; Chapiro E; Grelier A; Mould S; Barin C; Daudignon A; Gachard N; Struski S; Henry C; Penther D; Mossafa H; Andrieux J; Eclache V; Bilhou-Nabera C; Luquet I; Terre C; Baranger L; Mugneret F; Chiesa J; Mozziconacci MJ; Callet-Bauchu E; Veronese L; Blons H; Owen R; Lejeune J; Chevret S; Merle-Beral H; Leblondon V; ; ;
Haematologica; 2013 Apr; 98(4):649-54. PubMed ID: 23065509
[TBL] [Abstract][Full Text] [Related]
29. High dose chlorambucil in the treatment of lymphoid malignancies.
Nicolle A; Proctor SJ; Summerfield GP
Leuk Lymphoma; 2004 Feb; 45(2):271-5. PubMed ID: 15101711
[TBL] [Abstract][Full Text] [Related]
30. Waldenström's macroglobulinemia.
Gertz MA; Fonseca R; Rajkumar SV
Oncologist; 2000; 5(1):63-7. PubMed ID: 10706651
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic spectrum of Waldenström's macroglobulinemia: a single center experience.
Sajid R; Siddiqui SH; Shaikh U; Adil S
Indian J Pathol Microbiol; 2010; 53(3):490-3. PubMed ID: 20699509
[TBL] [Abstract][Full Text] [Related]
32. Fludarabine therapy in Waldenström's macroglobulinemia.
Thalhammer-Scherrer R; Geissler K; Schwarzinger I; Chott A; Gisslinger H; Knöbl P; Lechner K; Jäger U
Ann Hematol; 2000 Oct; 79(10):556-9. PubMed ID: 11100745
[TBL] [Abstract][Full Text] [Related]
33. Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.
Foran JM; Rohatiner AZ; Coiffier B; Barbui T; Johnson SA; Hiddemann W; Radford JA; Norton AJ; Tollerfield SM; Wilson MP; Lister TA
J Clin Oncol; 1999 Feb; 17(2):546-53. PubMed ID: 10080598
[TBL] [Abstract][Full Text] [Related]
34. Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Groupe Coopératif Macroglobulinémie.
Leblond V; Ben-Othman T; Deconinck E; Taksin AL; Harousseau JL; Delgado MA; Delmer A; Maloisel F; Mariette X; Morel P; Clauvel JP; Duboisset P; Entezam S; Hermine O; Merlet M; Yakoub-Agha I; Guibon O; Caspard H; Fort N
J Clin Oncol; 1998 Jun; 16(6):2060-4. PubMed ID: 9626204
[TBL] [Abstract][Full Text] [Related]
35. Fludarabine versus chlorambucil: is the debate over?
Rai KR; Hollweg A
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S7-9. PubMed ID: 22035752
[TBL] [Abstract][Full Text] [Related]
36. [Waldenstrom macroglobulinemia].
Kolyvanos Naumann U; Käser L; Vetter W
Praxis (Bern 1994); 2004 Mar; 93(14):547-52, 577. PubMed ID: 15125068
[No Abstract] [Full Text] [Related]
37. Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamide.
Dimopoulos MA; Hamilos G; Efstathiou E; Siapkaras I; Matsouka C; Gika D; Grigoraki V; Papadimitriou C; Mitsibounas D; Anagnostopoulos N
Leuk Lymphoma; 2003 Jun; 44(6):993-6. PubMed ID: 12854900
[TBL] [Abstract][Full Text] [Related]
38. Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil.
Kyle RA; Greipp PR; Gertz MA; Witzig TE; Lust JA; Lacy MQ; Therneau TM
Br J Haematol; 2000 Mar; 108(4):737-42. PubMed ID: 10792277
[TBL] [Abstract][Full Text] [Related]
39. Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patients.
Rourke M; Anderson KC; Ghobrial IM
Leuk Lymphoma; 2010 Oct; 51(10):1779-92. PubMed ID: 20795787
[TBL] [Abstract][Full Text] [Related]
40. Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphoma.
Keating MJ; McLaughlin P; Plunkett W; Robertson LE; O'Brien S; Gandhi V; Gregoire V; Yang L; Cabanillas F
Ann Oncol; 1994; 5 Suppl 2():79-83. PubMed ID: 8204523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]